Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Mbio
|
April 25, 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
Markus Hoffmann, Anzhalika Sidarovich, Prerna Arora, et al.
Cell Reports
|
April 27, 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Journal of Translational Medicine
|
November 20, 2024
The mononuclear phagocyte system obscures the accurate diagnosis of infected joint replacements
Robert Manasherob, Shay I Warren, Prerna Arora, et al.
Cellular & Molecular Immunology
|
October 26, 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
Prerna Arora, Cheila Rocha, Amy Kempf, et al.
Cell Reports
|
October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy
|
May 2, 2023
Arthroplasty for femoral neck fractures is at risk for under restoration of lateral femoral offset
Harsh N Shah, Andrew A Barrett, Andrea K Finlay, et al.
Cell Host & Microbe
|
May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
Prerna Arora, Lu Zhang, Nadine Krüger, et al.
International Journal of Molecular Sciences
|
November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
The Lancet. Infectious Diseases
|
September 18, 2022
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
Prerna Arora, Inga Nehlmeier, Amy Kempf, et al.
Vaccines
|
November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Mbio
|
April 25, 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
Markus Hoffmann, Anzhalika Sidarovich, Prerna Arora, et al.
Cell Reports
|
April 27, 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Journal of Translational Medicine
|
November 20, 2024
The mononuclear phagocyte system obscures the accurate diagnosis of infected joint replacements
Robert Manasherob, Shay I Warren, Prerna Arora, et al.
Cellular & Molecular Immunology
|
October 26, 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
Prerna Arora, Cheila Rocha, Amy Kempf, et al.
Cell Reports
|
October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy
|
May 2, 2023
Arthroplasty for femoral neck fractures is at risk for under restoration of lateral femoral offset
Harsh N Shah, Andrew A Barrett, Andrea K Finlay, et al.
Cell Host & Microbe
|
May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
Prerna Arora, Lu Zhang, Nadine Krüger, et al.
International Journal of Molecular Sciences
|
November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
The Lancet. Infectious Diseases
|
September 18, 2022
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
Prerna Arora, Inga Nehlmeier, Amy Kempf, et al.
Vaccines
|
November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Page
of 10